Author

S.-i. Hattori

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

H. Mitsuya· 2 shared A. Yaparla· 1 shared B. J. Y. Tan· 1 shared D. A. Davis· 1 shared H. Bulut· 1 shared H. Gatanaga· 1 shared H. K. Jaeger· 1 shared H. Katsuya· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

H. Mitsuya

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A widely-distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitro

K. Matsuda, S. Islam, T. Takada, K. Tsuchiya, B. J. Y. Tan, S.-i. Hattori, H. Katsuya, K. Kitagawa, K. S. Kim, M. Matsuo, N. S. Delino, H. Gatanaga, K. Yoshimura, S. Matsushita, H. Mitsuya, , K. Maeda

The paper develops a new assay to evaluate latency-reversing agents by eliminating HIV-1 proviruses in a long-term cell culture system.

Cell Reports Methods · Dec 1, 2021Peer-reviewedMicrobiology

Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300

D. A. Davis, H. Bulut, P. Shrestha, A. Yaparla, H. K. Jaeger, S.-i. Hattori, P. Wingfield, H. Mitsuya, R. Yarchoan

This study shows that SARS-CoV-2 main protease (Mpro) activity and dimerization are regulated by reversible glutathionylation of Cys300, offering a new target for antiviral agents.

bioRxiv · Apr 9, 2021Microbiology